Literature DB >> 11173715

Effects of a single bout of exercise and exercise training on steroid levels in middle-aged type 2 diabetic men: relationship to abdominal adipose tissue distribution and metabolic status.

P Boudou1, E De Kerviler, P Vexiau, J Fiet, G Cathelineau, J Gautier.   

Abstract

Lower androgen levels have been suggested to be associated with type 2 diabetes and central obesity and are probably involved into the development of atherosclerosis. The present study investigates the effect of acute and chronic exercise on Dehydroepiandrosterone (DHEA) levels in relation to abdominal fat distribution and metabolic status in type 2 diabetes. Twenty weight-stable, middle-aged males with type 2 diabetes were enrolled in the study and participated in a submaximal (VO(2) peak) and moderate (50% VO(2) peak) exercise bout. The subjects were randomly assigned either to a trained or a control group, respectively. Physical training consisted of an 8 week program of aerobic exercise (75% VO(2) peak, 45 min), twice a week and intermittent exercise, once a week, on a bicycle ergometer. Acute exercise significantly increased DHEA and Testosterone (T) levels. Physical training increased VO(2) peak (42%, p <0.001), insulin sensitivity index (K(ITT) ) (57.5%, p <0.02), and basal DHEA levels (36%, p <0.05), and decreased HbA1c (29%, p <0.001), visceral adipose tissue (VAT) (44%, p <0.01) and subcutaneous adipose tissue (SAT) levels (18%, p <0.01). Body weight, BMI and insulin, T levels were not modified. Changes in DHEA levels were not correlated with changes in insulin sensitivity and abdominal fat distribution. In conclusion, exercise training favourably affects DHEA levels independently of improvements of metabolic status and abdominal fat distribution in patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11173715

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  8 in total

Review 1.  The future of obesity reduction: beyond weight loss.

Authors:  Robert Ross; Alison J Bradshaw
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

2.  Effects of a 3-Month Physical Training on Cortisol and Testosterone Responses in Women After Bariatric Surgery.

Authors:  Marine Asselin; Nancy Vibarel-Rebot; Virgile Amiot; Katia Collomp
Journal:  Obes Surg       Date:  2022-08-03       Impact factor: 3.479

Review 3.  Is weight loss the optimal target for obesity-related cardiovascular disease risk reduction?

Authors:  Robert Ross; Peter M Janiszewski
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

4.  Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus.

Authors:  N G Boulé; G P Kenny; E Haddad; G A Wells; R J Sigal
Journal:  Diabetologia       Date:  2003-07-10       Impact factor: 10.122

Review 5.  Clinical outcomes and glycaemic responses to different aerobic exercise training intensities in type II diabetes: a systematic review and meta-analysis.

Authors:  Aimee Grace; Erick Chan; Francesco Giallauria; Petra L Graham; Neil A Smart
Journal:  Cardiovasc Diabetol       Date:  2017-03-14       Impact factor: 9.951

Review 6.  Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?

Authors:  Y S L Powrie; C Smith
Journal:  J Neuroinflammation       Date:  2018-10-16       Impact factor: 8.322

7.  Changes in body fat distribution and fitness are associated with changes in hemoglobin A1c after 9 months of exercise training: results from the HART-D study.

Authors:  Martin Sénéchal; Damon L Swift; Neil M Johannsen; Steven N Blair; Conrad P Earnest; Carl J Lavie; Timothy S Church
Journal:  Diabetes Care       Date:  2013-05-13       Impact factor: 19.112

Review 8.  Role of exercise in the management of diabetes mellitus: the global scenario.

Authors:  Zar Chi Thent; Srijit Das; Leonard Joseph Henry
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.